Equity Analysis

Quarterly Results

    Medicamen Biotech Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    531146
    INE646B01010
    159.056999
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    MEDICAMEQ
    47.69
    679.3
    EPS(TTM)
    Face Value()
    Div & Yield %:
    11.26
    10
    0.19
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2023Sep 2023Jun 2023
Gross Sales44.2042.6740.50
Other Operating Income0.000.000.00
Other Income 0.830.550.38
Total Income45.0443.2240.88
Total Expenditure 38.6236.5233.09
PBIDT6.426.707.79
Interest 0.650.910.96
PBDT5.775.806.83
Depreciation1.761.801.68
Tax0.991.191.25
Fringe Benefit Tax0.000.000.00
Deferred Tax0.26-0.20-0.51
Reported Profit After Tax2.773.014.42
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item2.773.014.42
EPS (Unit Curr.)2.192.383.49
EPS (Adj) (Unit Curr.)2.192.383.49
Calculated EPS (Unit Curr.)2.192.383.49
Calculated EPS (Adj) (Unit Curr.)2.192.383.49
Calculated EPS (Ann.) (Unit Curr.)8.759.5213.97
Calculated EPS (Adj) (Ann.) (Unit Curr.)8.759.5213.97
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity12.6512.6512.65
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)14.5215.7019.23
PBDTM(%)13.0513.5916.86
PATM(%)6.277.0510.91
Dividend Per Share(Rs)0.000.000.00
Diluted EPS2.192.383.49